This compound is primarily utilized in the development of antiviral medications, particularly for treating RNA virus infections. It serves as a key intermediate in the synthesis of nucleoside analogs, which are designed to inhibit viral replication by incorporating into viral RNA and disrupting its synthesis. Its fluorinated structure enhances stability and bioavailability, making it effective in therapeutic applications. Additionally, it is being researched for potential use in cancer treatment, where it may interfere with the replication of cancer cells by mimicking natural nucleosides and disrupting DNA synthesis. Its versatility and efficacy in targeting viral and cellular mechanisms make it a valuable component in pharmaceutical research and drug development.